GP-Leds

BCI seeks ‘good returns’ from newly launched capital solutions strategy

While more LPs are participating directly in CVs and secondaries transactions, such investors remain ‘the exception, not the norm’ in the market, according to BCI’s global head of PE.

Secondaries investors grow more comfortable with fund financing in CVs

Secondaries buyers are increasingly asking advisers to source fund financing for CVs to optimise returns, according to a speaker at the European Fund Finance Symposium.

From ‘status quo’ to ‘remain in place’: ILPA updates CV guidance for an evolving market

The industry body’s prior guidance was ‘silent on a lot of things’, chief executive Jennifer Choi tells Secondaries Investor.

Kline Hill leads on Plaza Ventures’ CV for digital advertising company

The deal gives Plaza more time with StackAdapt amid AI disruptions, with the firm’s investment considered one of the high-returning Canadian venture deals of all time.

Painswick brings PE focus to single-asset CVs

Painswick Capital views single-asset continuation vehicles as a PE business and has built its firm around that thesis, founder John Garcia and partner James Powers tell Secondaries Investor.

CalPERS’ new alts head takes sophisticated approach to secondaries

Anton Orlich, architect of the US pension giant’s PE turnaround, will now also be responsible for its private credit, real estate, infrastructure and other alternative programmes.

Blue Owl leads Veld Capital’s €355m credit CV

The CV includes follow-on capital to ‘capitalise on a strong pipeline already in place’, according to a statement shared with Secondaries Investor.

Fees and expenses survey: Seven key takeaways

Market participants have a keen eye on fees and expenses related to GP-led deals given many LPAs were not drafted with these transactions in mind.

Hong Kong-based Coller principal departs

The former investment principal, who covered secondaries transactions in India, Australia and Southeast Asia, joined the firm in 2011 in London.

Top performing CVs continue to show outperformance over buyout funds – Evercore

Evercore and HEC Paris’s fifth CV performance study includes 396 CVs formed between 2018 and 2024, a significant increase on the 140 funds analysed in the inaugural report.